Cogent Biosciences, Inc.

Pharmaceutical Preparations·WALTHAM, MA·FY end 12/31·CIK 1622229

CEO Pay Ratio

95:1

Andrew Robbins

CEO Total Comp

$27.8M

Andrew Robbins

Median Employee

$292,285

Revenue

—

FY 2025

Net Income

-$328.9M

FY 2025

Free Cash Flow

-$266.0M

FY 2025

Net Margin

—

Insider Net (180d)

-$764.4M

0 buys / 12 sales

CEO Pay Accountability

CEO comp as % of net income

-8.44%

For every $1,000 of profit, $-84.40 flows to the CEO.

CEO comp as % of buybacks

—

No buyback data for the most recent fiscal year.

5-year history · USD

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	Trend
Revenue	—	—	—	—	—	—
Gross Profit	—	—	—	—	—	—
Operating Income	-$333.4M	-$275.9M	-$208.1M	-$147.8M	-$75.6M
Net Income	-$328.9M	-$255.9M	-$192.4M	-$140.2M	-$72.3M
Operating CF	-$264.4M	-$207.8M	-$153.6M	-$118.6M	-$58.8M
Capex	$1.6M	$573.0K	$2.8M	$6.9M	$1.7M
Free Cash Flow	-$266.0M	-$208.4M	-$156.4M	-$125.5M	-$60.5M
Buybacks	—	—	—	—	—	—
Dividends	—	—	—	—	—	—

Gross Margin	—	—	—	—	—	—
Operating Margin	—	—	—	—	—	—
Net Margin	—	—	—	—	—	—
FCF Margin	—	—	—	—	—	—
R&D / Revenue	—	—	—	—	—	—
Effective Tax	—	—	—	—	—	—
Debt / Equity	0.35	—	—	—	—	—
Buybacks / FCF	—	—	—	—	—	—

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Andrew RobbinsChief Executive Officer	$724.6K	$13.0M	$13.4M	$583.2K	$14.0K	$27.8M
Jessica SachsChief Medical Officer	$549.4K	$4.5M	$3.7M	$333.2K	$14.0K	$9.2M
John RobinsonChief Scientific Officer	$532.0K	$4.5M	$3.7M	$322.7K	$14.0K	$9.2M
Cole PinnowChief Commercial Officer	$482.3K	$4.5M	$3.5M	$258.3K	$14.0K	$8.8M
John GreenChief Financial Officer	$510.7K	$4.0M	$3.7M	$309.6K	$14.0K	$8.5M